Lexicon Pharmaceuticals, Inc.

TX · United States · Reporting entity ID 100000181746

Total reported 2019–2025

$28.9M

#248 of 2,960 reporting companies — 0% of all reported industry payments

$4.20M in general payments across 38,266 records, plus $24.7M in research funding across 2,861 records.

How it breaks down

General payments $4,199,859

Research funding $24,669,968

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.